The closure of a crucial Rhode Island bridge for safety reasons in 2023, and the traffic nightmare that followed, have dogged Gov. Dan McKee in the Democratic primary.
Category: CVS Caremark Corporation
-
This Governor Could Lose His Primary. A Bridge May Be to Blame.
The New York Times – On the Runway: -
Health Insurance Giants Are Fighting Efforts to Break Them Up
The New York Times – Business:UnitedHealth Group, CVS Health and Cigna are suing states over new laws targeting their pharmacy businesses.
-
Insurers’ Delays in Approving Medical Care Persist, Despite Promises
The New York Times – Business:Doctors and patients complain that the controversial practice of prior authorization for treatment and procedures is still widespread.
-
CVS Holds Off on Offering Covid Vaccines in 16 States
The country’s largest pharmacy chain said it needed a C.D.C. panel to recommend the shots before it could offer them nationwide.
-
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
-
Florida Seeks Drug Prescription Data With Names of Patients and Doctors
The state’s insurance regulator has demanded detailed information about patients and their medications, raising privacy concerns.
-
New CVS App Lets Customers Unlock Cabinets to Pick Up Products
The company said the unlocking function, part of a pilot program in New York City, will be expanded this year.
-
Drugmakers Paid PBMs Not to Restrict Opioid Prescriptions
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.
-
Bipartisan Lawmakers Seek to Break Up Giant Health Care Conglomerates
New legislation would force UnitedHealth Group, CVS Health and Cigna to each sell their pharmacies within three years.
-
The Powerful Companies Driving Local Drugstores Out of Business
The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
-
CVS Ousts Karen Lynch as C.E.O. and Shares Fall
Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state of the company’s finances.
-
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.